FLAG-KRAS4B as a Model System for KRAS4B Proteoform and PTM Evaluation by Mass Spectrometry
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces a new method to analyze KRAS4B protein modifications using FLAG-tagged KRAS4B and mass spectrometry. This approach enhances the detection and validation of posttranslational modifications (PTMs) in cancer research.
Area Of Science
- Biochemistry
- Proteomics
- Cancer Biology
Background
- Previous top-down mass spectrometry identified novel posttranslational modifications (PTMs) on KRAS4B proteoforms.
- Low signal from endogenous KRAS4B hindered the characterization of less abundant PTMs and validation efforts.
- The NCI RAS Initiative developed a model system for stable expression of N-terminally FLAG-tagged KRAS4B in cancer cell lines.
Purpose Of The Study
- To present a method combining immunoprecipitation with mass spectrometry for direct analysis of N-terminally FLAG-tagged KRAS4B proteoforms and PTMs.
- To enable more effective visualization and validation of KRAS4B PTMs, including low-abundance modifications.
Main Methods
- Stable expression of N-terminally FLAG-tagged KRAS4B in cancer cell lines.
- Immunoprecipitation for purification of FLAG-KRAS4B.
- Targeted top-down liquid chromatography-tandem mass spectrometry (LC-MS/MS) for proteoform analysis.
- Bottom-up LC-MS/MS for PTM validation.
Main Results
- Successful purification of FLAG-KRAS4B from cancer cell lines.
- Detailed proteoform analysis using targeted top-down LC-MS/MS.
- Validation of abundant PTMs using bottom-up LC-MS/MS with provided example results.
Conclusions
- The developed method effectively analyzes N-terminally FLAG-tagged KRAS4B proteoforms and PTMs.
- This approach overcomes limitations of low endogenous signal for PTM characterization and validation.
- The protocols facilitate deeper understanding of KRAS4B modifications in cancer contexts.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.